Bacteria-scale robots that can run for months without human control are no longer a lab fantasy. Researchers have now built ...

To address persistent flooding in Bulacan province, the Department of Public Works and Highways  is considering science-based ...

The proposed P6.793-trillion national budget for 2026, as approved by the House of Representatives and the Senate, has ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

As the season moved through its final days of December, the broader competitive picture began to sharpen. Early ...

Michigan football culture deteriorated under Sherrone Moore according to those in and around the program. Cracks appeared ...

Solana price remains a focal point as it responds to both institutional alignment and shifting technical structure. Notably, corporate treasury strategies ...